Entra in Area Pazienti Pagina Facebook della Siu Pagina Twitter della Siu

Articolo 3

Final results of the European Advanced Renal Cell Carcinoma Sorafenib (EU-ARCCS) expanded-access study: a large open-label study in diverse community settings. 

Beck J, Procopio G, Bajetta E, Keilholz U, Negrier S, Szczylik C, Bokemeyer C, Bracarda S, Richel DJ, Staehler M, Strauss UP, Mersmann S, Burock K, Escudier B.
Ann Oncol. 2011 Feb 15.

caricamento in corso...

Letto 3068 volte